Xu S, Laccotripe M, Huang X, Rigotti A, Zannis V I, Krieger M
Department of Biology, Massachusetts Institute of Technology, Cambridge 02139, USA.
J Lipid Res. 1997 Jul;38(7):1289-98.
The class B type I scavenger receptor, SR-BI, binds HDL, mediates selective uptake of HDL cholesteryl esters by cultured cells, and its expression is coordinately regulated with steroidogenesis in several endocrine tissues (adrenal, ovary, testes). SR-BI can also bind LDL and anionic phospholipids, which raised the possibility that HDL apolipoproteins might not participate directly in HDL binding. We have examined the ability of individual human HDL apolipoproteins (apoA-I, apoA-II, and apoC-III) reconstituted into phospholipid/unesterified cholesterol complexes to bind to murine SR-BI (mSR-BI) expressed in stably transfected cultured cells. All three apolipoprotein/phospholipid/unesterified cholesterol complexes specifically associated with mSR-BI expressing cells with high affinity and competed for the binding of HDL, while apolipoprotein-free complexes did not. Furthermore, lipid-free forms of these soluble apolipoproteins also competed for HDL and apolipoprotein/ phospholipid/cholesterol complex association with mSR-BI, but locust high density lipophorin and bovine serum albumin were not effective competitors.Thus, all three of the HDL apolipoproteins (apoA-I, apoA-II, and apoC-III) tested can directly mediate binding to mSR-BI, and this multiligand apolipoprotein receptor may be responsible for at least some of the multilipoprotein and apolipoprotein binding activity previously observed in cells and tissues.
B类I型清道夫受体SR-BI可结合高密度脂蛋白(HDL),介导培养细胞对HDL胆固醇酯的选择性摄取,并且其表达在多个内分泌组织(肾上腺、卵巢、睾丸)中与类固醇生成协同调节。SR-BI还可结合低密度脂蛋白(LDL)和阴离子磷脂,这增加了HDL载脂蛋白可能不直接参与HDL结合的可能性。我们研究了重组到磷脂/未酯化胆固醇复合物中的个体人类HDL载脂蛋白(载脂蛋白A-I、载脂蛋白A-II和载脂蛋白C-III)与稳定转染的培养细胞中表达的小鼠SR-BI(mSR-BI)结合的能力。所有三种载脂蛋白/磷脂/未酯化胆固醇复合物均以高亲和力与表达mSR-BI的细胞特异性结合,并竞争HDL的结合,而无载脂蛋白的复合物则不结合。此外,这些可溶性载脂蛋白的无脂形式也竞争HDL以及载脂蛋白/磷脂/胆固醇复合物与mSR-BI的结合,但蝗虫高密度脂蛋白和牛血清白蛋白不是有效的竞争者。因此,所测试的所有三种HDL载脂蛋白(载脂蛋白A-I、载脂蛋白A-II和载脂蛋白C-III)均可直接介导与mSR-BI的结合,并且这种多配体载脂蛋白受体可能至少对先前在细胞和组织中观察到的一些多脂蛋白和载脂蛋白结合活性负责。